Rhumatologie

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial

Rheumatology (Oxford) 2009;48:1429–34. Martin Soubrier, Xavier Pue´chal, Jean Sibilia, Xavier Mariette, Olivier Meyer, Bernarde Combe, Rene Marc Flipo, Denis Mulleman, Francis Berenbaum, Charles Zarnitsky, Thierry Schaeverbeke, Patrice Fardellone and Maxime Dougados

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of disease activity for patients with axial spondyloarthritis
Rhumatologie

Impact of disease activity for patients with axial spondyloarthritis

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis
Rhumatologie

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France